Based upon the link of RGS16 regulating several oncogenic pathways and the decreased expression of RGS16 in metastasized pancreatic cancer, we chose to further study the function of RGS16 in pancreatic cancer in order to identify the role it has in the p53 and pRb signaling pathways. This evidence concerns the gene TP53 and familial pancreatic carcinoma.